For the year ending 2025-12-31, NUVB has $594,822K in assets. $289,106K in debts. $164,086K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 164,086 | |||
| Accounts receivable, net of allowance for credit loss of nil and nil | 16,076 | |||
| Inventory | 11,411 | |||
| Prepaid expenses and other current assets | 11,536 | |||
| Marketable securities | 365,125 | |||
| Interest receivable on marketable securities | 3,285 | |||
| Total current assets | 571,519 | |||
| Total property and equipment | 1,748 | |||
| Less accumulated depreciation and amortization | 1,184 | |||
| Property and equipment, net of accumulated depreciation of 1,184 and 874, respectively | 564 | |||
| Intangible assets, net of accumulated amortization of 1,856 and 448, respectively | 11,214 | |||
| Operating lease right-of-use assets | 3,918 | |||
| Other non-current assets | 7,607 | |||
| Total assets | 594,822 | |||
| Accounts payable | 9,479 | |||
| Current operating lease liabilities | 1,880 | |||
| Contract liabilities, current portion | 7,515 | |||
| Liability related to revenue interest financing agreement, current portion | 9,585 | |||
| Short-term borrowings | 5,724 | |||
| Warrant liability | 2,865 | |||
| Accrued expenses | 45,183 | |||
| Total current liabilities | 82,231 | |||
| Warrant liability | 0 | |||
| Contract liabilities, net of current portion | 11,305 | |||
| Non-current operating lease liabilities | 2,543 | |||
| Non-current liability related to revenue interest financing agreement, net of deferred financing costs of 4,241 and 0, respectively | 145,819 | |||
| Long-term borrowings, net of deferred financing costs of 3,042 and 0, respectively | 47,208 | |||
| Total liabilities | 289,106 | |||
| Class a and class b common stock and additional paid in capital, 0.0001 par value per share 1,060,000,000 (class a 1,000,000,000, class b 60,000,000) shares authorized as of december 31, 2025 and december 31, 2024, 346,503,675 (class a 345,503,675, class b 1,000,000) and 337,837,872 (class a 336,837,872, class b 1,000,000) shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 1,421,273 | |||
| Accumulated deficit | -1,115,370 | |||
| Accumulated other comprehensive income | -187 | |||
| Total stockholders' equity | 305,716 | |||
| Total liabilities and stockholders' equity | 594,822 | |||
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)